Manuel Serrano: “I don’t know how to use the word immortality. I don’t see any point in talking about something so intangible”
Manuel Serrano is internationally recognised in the field of tumour suppression. In addition to his discovery of the p16 gene, one of his most important discoveries has been the identification of cellular senescence as a main anti-oncogenic response. In this the second edition of Longevity World Forum, he will share his extensive experience, as well as the advances on which he is currently working at the Institute for Research in Biomedicine (IRB Barcelona).
SENS Research Foundation, co-founded by Aubrey de Grey, renews its commitment to the Longevity World Forum
This institution, a global reference for its research into aging, has signed a sponsorship agreement with the congress for the second consecutive year. One of its most renowned representatives, Maria Entraigues Abramson, will participate at the conference which will be held in Valencia on 14 and 15 November.
SENS Research Foundation, cofundada por Aubrey de Grey, renueva su compromiso con el Longevity World Forum
Esta institución referente a nivel global por su investigación sobre envejecimiento ha firmado por segundo año consecutivo un acuerdo de patrocinio con el congreso. Una de sus representantes más reconocidas, Maria Entraigues Abramson, participará en las jornadas que tendrán lugar el 14 y el 15 de noviembre en Valencia.
Life expectancy and healthy ageing, under debate in Spain at the Longevity World Forum
The second edition of this congress, which is breaking new ground in Europe, will take place on 14 and 15 November in the Palacio de Congresos Conference Centre in Valencia and will bring together some of the world’s most renowned professionals, such as Rafael de Cabo, Manuel Serrano and Álvaro Pascual-Leone.
Google’s Calico renews its support for the Longevity World Forum, Spain’s most important congress on ageing
Google’s biotechnology company sponsors Europe’s pioneering congress on life expectancy and healthy ageing for the second year running.
Pedro Almaida: “As the circadian system ages, an organism’s ability to adjust its biological rhythms to environmental cycles is compromised”
Dr. Pedro Almaida has been researching the circadian system for years. His participation in the 2019 Longevity World Forum will give him the opportunity to explain its importance in terms of healthy ageing and to report on the latest discoveries in this field.
Carlos F. Sánchez Ferrer: “Drugs that are able to inhibit the actions of adipokines can have a beneficial effect on arteries and can even reverse vascular aging”
Professor Carlos F. Sánchez Ferrer will explain in #Longevity19 the new pharmacological targets as far as vascular ageing is concerned.
Manuel Collado: “Our goal must be to reach an advanced age in a better state of health and to remain free of disease as long as possible”
Dr. Manuel Collado will be one of the speakers in the first session of #Longevity19, which will focus on will be one of the speakers in the first session of #Longevity19, which will focus on exploring longevity by presenting different research, from basic to applied, that is currently being carried out in this field. In this brief interview, he offers an insight to his perspective and to his work.
Longevity World Forum focuses its second edition on scientific innovation and healthy aging
The Longevity World Forum choses Valencia once more and will be held on 13 and 14 November at the city’s Palacio de Congresos. This year’s meeting will again bring together internationally renowned professionals, such as Rafael de Cabo, Manuel Serrano and Álvaro Pascual-Leone.
Longevity World Forum confirms Valencia as its venue in 2019
The first conference on longevity in Europe will once again make Valencia the world scientific capital. This global meeting will be held for the second time on 13 and 14 November at the city’s conference centre.